this chipoltle thing >> delicious >> i ain't scared. enough earnings. >> tip. >> whit: his wheelchair over >> thanks for watching see you back here tomorrow at 5:00. my mission is simple, to make you money i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now >> hey, i'm cramer welcome to "mad money. welcome to cramerica call me or tweet me @jim cramer what happens if people actually start getting interested in the stock market

what happens if regular investors actually begin to buy individual stocks again? it's something we need to consider as the averages hit still one more all-time high records. down gaining 66 points, s&p advancing .45%, nasdaq climbing .64%. another ton of statistics showing an almost inexorible decline in the interest in the stock market as a whole. there are entire outfits that exist to scare you out of picking stocks, telling you that it's a fool's game because of the dreaded single-stock risk. they say you're worried that you could buy a total loser and it would destroy your nest egg, which is why they're so eager to sell you this night etf that will sell you the both winners and loser. but there's something afoot now,

after nine straight sessions where the nasdaq has rallied a total of 4.7%, there's something going on, at least anecdotally these days when i'm stopped on the street by random passersby, i'm beginning to get actual questions about lots of individual stocks again. not how's the market individual stocks. i'm also getting a lot of thanks along with questions about names we've held on the show that have worked out i'm most grateful. understand the wise guys out there will say forget it, nothing define as top more than when some random person who usually just wants a selfie with me is now asking about stocks. come on, you know you can hear the cat calls from miles away, right? this analysis is reminiscent of proverbial shoe shine boy in 1928 who bought rca at $400. or the cab driver bragging about

his worldcom in 1999, a company that ultimately proved to be a giant fraud! >> they know nothing >> however, that kind of dismissal i'm saying right here, right now could be very well why? because the phenomena is just getting started. you don't bet against individuals when they start chatting me up, though my wife refers to me as a dollar sign represented by a man let me give you examples that might make you feel the real single-stock risk is the risk of missing out on these winners last week i had lunch with a man known for his fabulous charitable work, a leader of a great institution for multiple decades. the conversation turned to the stock market and how amazing it's been. he said to me, you know, one of my kids talked me into buying some amazon a while back so i bought $100,000 worth

i looked a it the other day. it's worth 8 million. pretty good for listening to your kids. i'd say so i'd also say amazon was one of the most gettable gains in the history of -- in the history of the stock market given its endless dominance and the wonders of amazon prime that so many of you partake in you know what? it's still not too late to buy even over a thousand bucks now, you know nvidia's been on fire here nvda symbol. it traded add $64 this time las year it's now at $165 whenever i had a winner in my hedge fund, i named miech pets of a that. we adroppopted a gray cat in 19 called her flow.

when a stray black cat found her way to us, i named her bessie, after the beth lehem steel, whih had shorted from $25 to zero we even had a cat we called comag. she was named after the stock of a disc drive component that gave as you five-bagger she was sadly hit by an 18 wheeler and, yes, indeed she did bounce of a that unfortunate incident and that was the end of the moniker mongrel naming era but lately with this new found enthusiasm for stocks, i renamed ef re everest, our rescue mutt, nvidia i gave him names for nvidia's

competitors. he a real go gert litter like t company's management since the rechristening, i've had not one, not two, but three patrons at my mexican place m brooklyn tell me they bought nvidia after they heard me rename that mongrel for the red hot semiconductor stock. now, i'm not a total bozo about this stuff in each case if i'm feeling really kind of spry, i say wait a second, did you do any homework whatsoever before you pulled the trigger again, i got a mouthful every time all three ticking off the litany of what makes nvidia particular. chips for self-driving cars, chips for gaming they knew the story, not just the dog. one day they'll just know the dog and it will be time to ski

dadle. when you can go random stocks, that's a good sign and i'll continue to post pictures of nvidia i would have called him downright stupid, which is why i'm surprised he answers to anything that's dinner yesterday, a guy asked me if ali baba is still good i said why did you buy it? he said i watched the show he said it made sense to buy it. he said he wanted to know if i changed my mind, was alibaba too expensive? that's a rational question i said hold on

i am thanked every day for facebook or apple or net book. it helps people hold on, not trading in and out like wall street will tell to you do always the skeptic about the voxpopuli component and i was surprised, they no a lot one person stopped me if universal play was still a good play, even though it's been warring. the answer, yes. another quoted ware buffett that's cheaper than the other likes procter & gamble needless to say people bought facebook and netbooks because they loved the companies i always ask those who own the former, what do they think of instagram? just to be sure they know that facebook owns it and competes against it

they always know and someone asked me how high broadcom could go? i felt like deferring my judgment to him. a father of a kid i know bought gaming stocks because the kid was wise to the work of eastport and had done some pohomework someone told me they researched herman miller. liked the consistency. another bought costco, that it's a good enough operator that it could co-exist with amazon i have to say i agree. people are beginning to wake up to the idea that owning the stocks of companies they love after doing some homework, not just index funds but in addition to them, turn out to be very lucrative. if that's the case, then that means some real fire power i mean genuine, billions and

billions of dollars could come off the sidelines, which means we might have more room to run, even from these levels let me give you the bottom line. until i bump into someone who has bought the stock of nvidia because my dog comes running when i shout it and not because the investors knows what it does, i'm tempted to say let her ride why not. let's say you bought amazon, say you put $10,000 in amazon back in the day, not $100,000, you'd still have 800,000 okay, not 8 million. but as we used to say on the trading desk, better than the sharp stick in the eye and certainly a good argument to try to find the next amazon. let's take calls and go to steve in ohio. steve! >> caller: mr. cramer, thank you for taking my call >> my pleasure >> caller: my call tonight is in regards to natural gas and specifically chesapeake energy

i've been reading, seeing reports that natural gas may be heading to a price of $5, $6, and i'm wondering about chesapeake if their financials have, in your opinion, turned around and if they would benefit -- >> you're in ohio where there's some tremendous chesapeake fields natural gas does need to go to 4, 5 to go up to a sizable appreciation i don't think it's going to do it there have been a series of discoveries not talked about within the last three months of natural gas that's going to make it no idea how much we got of this stuff unless we have an extremely cold winner, you're going to see natural gas go down to 2.50. i'll throw in southwest. don't want to do that one either ann marie in new york. >> caller: thanks for taking my call >> okay. >> caller: i am in a house of pain with chipotle do i continue to practice patience and discipline or take

a loss >> i have got to tell you, ann marie, had i saw that news about the norovirus, in 2016, ann marie, you got to reset the clock now. it's going to start all over again because the publicity is to the going to go away. people are going to question both the business model and the management so my answer is that stock is not done going down. a bad break but it's what happens. all right. now, we continue to get hit with a series of records and that's a daily reminder of why you need to stay in this game no one ever got hurt taking a profit you want to ring the register on some stuff, that's fine. but there's a lot of good coming off the sidelines. "mad money" tonight. my hunt for the radar market continues with a fin player you

may not have heard of. i'm tauging you through the m and a frenzy and could it continue to go higher i'm going to talk to the ceo so stick with cramer >> announcer: don't miss a second of "mad money." follow jim cramer. tweet jim, send jim an e-mail or give us a call miss something head to madmoney.cnbc.com. we, the people, are tired of being surprised with extra monthly fees. we want hd. and every box and dvr. all included.

because we don't like surprises. yeah. like changing up the celebrity at the end to someone more handsome. and talented. really. and british. switch from cable to directv. get 4 rooms with hd, dvr, and every box included for $25 a month.

a used car, hey you've gotta see this. cno.n. alright, see you down there. mmm, fine. okay, what do we got? okay, watch this. do the thing we talked about. what do we say? it's going to be great. watch. remember what we were just saying? go irish! see that? yes! i'm gonna just go back to doing what i was doing. find your awesome with the xfinity x1 voice remote.

the thing about this market is that it's not defined by the high-profile tech leaders that you hear about all the time. this rally is all about a silent majority a silent majority of quiet, humble, low-profile stocks that just keep climbing they are the unsung heros of the stock market and that's why i spent all month trying to highlight these totally boring, totally unsexy stocks that nevertheless are a microcosm of what's working names like avery denison, brinks, rockwell collins. tonight i've got another one, equifax, efx, best known for being one of the major credit reporting agencies when banks make a decision on whether or not to lend you money, they check your equifax

credit coscore. its stock is on fire it managed to rally 20% year to date longer term gains are stag aring. over the last five years, they've nearly tripled, dramatically outpacing the s&p 500 gain over a five-year period how did they do it they see themselves as a global information solutions company. they use unique data, technology and analytics to provide insights to more than 820 million consumers and 90 million businesses worldwide a lot of this is related to credit reporting when you go to the bank to get a mortgage, equifax charges them a fee to check your credit score they also have a workforce solution decisions where they help employers verify their

workers are who they say they are, as well as doing human resource outsourcing and they have a smaller consumer focus business where they sell subscription based credit monitoring and do identity theft protection products. they take the saturday data they use to tell banks whether you're a responsible borrower and sell it back to you if you're not signed up for a credit platform monitoring, i think you should be. they make mistakes all the time and when that happens, you need to bother them until they correct it in all this sounds really dull, that's because it is if you want to put someone to sleep, start a conversation about credit scores. however, this market loves dole. equifax is the kind of boring, slow and steady company that's been embraced by wall street

lately they want reliability. wall street wants consistency. equifax is old it started trading on the new york stock exchange in 1971. after not doing much for decades, its stock has nearly tripled since the summer of 2012 why has the stock suddenly caught fire? simple -- the numbers have just gotten better and better and then a lot better. for starters, the company has accelerated revenue growth, we call that arg. in 2014, equifax grew sales at about a 5.8% clip, 2015, 9. 3% and last year increased by 11.1%. this a really old company. that's remarkable. their operating income keep rising while margins hold steady for the last four years. talk about consistency in the last four years, it's

margins started expanding again. put together and you get an earning explosion. it rose to 15% and rose to 27% last year. that is a terrific number. how do they do it? i think they've benefited enormously from the rise of data-driven decision making and all sorts of businesses. we talk about machine learning, artificial intelligence, in is the kind of thing you should be thinking about look at finance. in recent years we've seen sofi, and the common thread is these companies come up with a way to improve the lending process, often using computer algorithms to replace loan officers but that on works if they have huge piles of data the best data you can find here is the kind of consumer credit info that's equifax's bread and

butter it's not just the banks. these days everyone wants to see your credit score, car dealers to phone companies to advertising agencies who want to do more targeted marketing they need this database. given all these friends, there's no sense they've been growing. same is true for their credit s creditors, transunion. the company is very well matched. it has a mix of new you are, faster growing business, u.s. information services disvision when a business is young, equifax is aggressive at pursuing growth. as the business matures, the company goes all in on cost cuts to milk it for everything they're worth. on the growth side, they've made a series of acquisitions, more than a des purchases, priding the leading credit analysis group in new zealand that closed last year. they are in the process of taking offer the world and that

bolsters their growth rate this company reports again next quarter. you might get a buying opportunity. they delivered a 3% earnings beat with higher revenue up year after year the company's revenue growth continues to accelerate. they gave relative conservative guidance which caused a minor selloff. if the company gives ydoes that, could you get an opportunity to buy. i say look at the mortgage number we just saw last week applications shot up 6.3% as buyers rush to refinance i think it will be a long time before higher rates present any kind of threat to there company. i know all the home building companies agree with me. plus, even after its run, the company stock is relatively inexpensive. it's not cheap but less pricey

than you might expect. here's the bottom line this rally is not about the stocks of -- i should say not just about the stocks of sexy, high-profile companies like fang it's about boring, slow and steady companies that just don't get enough appreciation from investors or certainly from the media. stocks like equifax. i think there's more up side my recommendation is you buy only a little at these levelsuntil exwhich fax reports next thursday at which point i would be more aggressive if it came in. coming up, more on the m&a take. and a medical device play that could help fill your heart and portfolio. will innovative implant help edwards life sciences' stock do better i'll talk to the ceo stocks may triple this year and you may never have heard of it and i'll reveal it

stick with cramer.

stocks may triple this year and

sometimes the gods of mergers and acquisitions make my job easy by pure chance today we have not one but two deals that explain the current landscape. the discovery in script works interactive merger and the sale of french's franks red hot and barbecue source to mccormick's the scripts deal at $10 million is twice the side of the food transaction and both those stocks went up by the way, these are happening for similar reasons. companies afraid of losing relevance in their clout are merging with peers or rivals to attract more to their entity

consider the cable company and supermarket has similar distribution methods you stroll through the aisles of the supermarket to find product. you dial around the cable to do the same thing however, there's a ghetto in the supermarket, a ghetto called the center of the store. there says slew of slow-to-no-growth planned challenged by the lack of traffic. the merchandise is supposed to go from the ghetto to your pantry but as we know, millennials want fresh, not canned goods many don't even have pantries. consider your cable offerings. there's knows that you watch and then all those that you skip over isn't that like the center of the center grocery session along come willing acquirers trying to break out of their not

so hot areas and challenge distribution millennials are not interested in canned food like their parents were scripts is the it will vision equivalent of canned pantry food the brands they are selling to mccormack french's mustard, frank's red hot and cattleman's barbecue sauce are all distributed in a veritable wilderness of canned goods that are now threatened by upstarts like sir kensington's, just bought by the power house that is unilever. or the loved siracha can these deals work the companies have no choice but to try mccormack has been on a buying spree to get more spices under the hood french's, to me, old bay

seasoning, that's one of their traditionals they've added -- well, let's put it this way. this one has to work it's the ultimate -- when i look at french's, it's the ultimate opportunity, isn't it? think about it it's a throw bakamus tard, right? it's crayon-like yellow. it seems almost cartoonishly unnatural. i always thought had it enough preservatives to rival velveeta as a condiment that can survive nuclear war and still taste good on pretzels. millennials like adding things to food that has spice but doesn't make you fat so you can look your selfie best. mustard has a lot fewer calories than mayo or butter. but i think tear paying too much for these products ion how combination will

actually work. not bad. but the market know, the stock got hammered for 5 bucks, more than 5% but they fit with the company's understanding that these days people want to stay home and cook using mccormack spices and a whole slew of kondments. that's why mccormick made keyeser an offer it couldn't refuse in a world of core cutters, i can see many millennials not wanting to watch diy, hgtv or food channels because they rent houses in record numbers rather than owning them however, they do still like to cook the cable companies will need to squeeze these guys if they want to make money. don't think of these deals as growth makers. they're defensive deals done to stay relevant in a difficult marketplace where every way they used to get customers is now up in the air while merchandise is at an all-time lower and going

forward i bet we see a lot more mergers of a similar path. let's go to bob of new jersey. bob. >> caller: it's jim of new jersey how are you? >> i'm okay, man how are you? >> caller: all right you're my favorite guy on tv >> thank you >> have a question about hormel food, one of the dividend kings. they've been on a downward trend for a year now trading at 33 a share. is it time to buy more or stand down >> they were involved with some of the bidding on some of these brands i'm going to stay away for hormel because it's not the right time in the actual sector rotation we're having to own such a defensive stock let's stay away for now. andy in new jersey, please andy >> caller: hey, jim. >> hey >> caller: what are your thoughts on snap ink as it relates to augmented reality and do they have any proprietary technologies that make them more valuable than solely be

considered a marketing platform? >> i think the guys that run the company are having an augmented reality, you're supposed to make money. >> snap is the number one reason you want to own facebook discovery, scripts and franks red hot and mccormick was a necessary tie-up it's defensive it won't buy a lot of growth i'm giving one medical device player a checkup could its new heart products keep hearts pumping? and a company that's rocketed over 80% in the past month alone. and rapid fire in tonight's edition of "the lightning round. so stick with cramer

experience advanced safety technology at the lexus golden opportunity sales event before it ends. choose from the is turbo, es 350 or nx turbo for $299 a month for 36 months if you lease now. experience amazing at your lexus dealer. you myour joints...thing for your heart... or your digestion... so why wouldn't you take something for the most important part of you...

your brain. with an ingredient originally found in jellyfish, prevagen is now the number one selling brain health supplement in drug stores nationwide. prevagen. the name to remember.

to keep our community safe. before you do any project big or small, pg&e will come out and mark your gas and electric lines so you don't hit them when you dig. call 811 before you dig, and make sure that you and your neighbors are safe. 811 is available to any business our or homeownerfe. to make sure that you identify where your utilities are if you are gonna do any kind of excavation no matter how small or large before you dig, call 811. keep yourself safe.

what are we to make of cramer fav edward life sciences, focused on fighting heart disease, revolutionary noninvasionive heart valve replacement. the medical device stocks roared higher and edward led the way. while they lost their mojo falling from 121 all the way down to 80 right before the election, it's come roaring back it is up to 119 as of today. edwards has given as you 27% game in 2017 right now it's in its quiet here, the company reports next week we're not going to talk about anything near term we want to talk about some of the innovations in the broader

medical device industry. let's get a big picture read on the business welcome back to "mad money." good to see you, sir >> good to see you, sir. >> i first got to know you when my father was in the hospital in pennsylvania one person said you have got to hear about this edwards lif lifesciences, they are cracking open people. how did do you it? >> it's a long story there's been a great evolution in technology. and certain patients their life depends on surgery this idea came about it's now almost 20 years ago and the first implant done about ten years ago and it's revolutionized really the treatment for these patients so think about the fact that rather than opening a person's chest, stopping their heart -- i can run you through a quick try

stro history. >> sure, do. >> our company was created by lowell edwards and when the ventricle squeeze, the valve opened and then it closed, it saved a lot of people's lives. some of the problems, though, blood thinners were necessary to keep blood clots from forming. 20 years later, the advent of tissue valves. they started out as pig heart valves, they were the closest thing to human anatomy and ultimately exists today. this is the leading heart involve today, opens and closes just beautifully the break through was could you make a heart valve and this it the market leading valve, the sapien, could you make a involve, squeeze it on to a balloon catheter and during the procedure be able to introduce

it in a small hole in the upper thigh, introduce it to the diseased valve and as shown in this model, start opening and closing, beating and keeping the patient alive. >> within how much time? >> the whole procedure takes often less than an hour and -- >> the treatment would be how many hours and how much time lost >> it would be hours and your blood would be pumped through a machine -- >> and patients would stay in the hospital forever >> that's the bigger issue especially the older patients, they would be in the hospital for more than a week and even once they got home from the hospital, it would be a tough recovery, cognizant deficits >> when can people go back to work >> the rate has been falling as they've been improving, it's just a matter of days now. >> it's one of the most major procedures >> there are a lot of procedures today where people are going home the same day, they're not even under anesthesia, they're

awake and their physician is speaking to them >> the way you want to think about it is the total cost of the procedure. the total cost of the old procedures versus the new one, it's quite effective to do the new way. it's not that often where we have these inkred icredible sols that have better outcomes, improved quality of life, and you have better economics. this is one of those triple wins >> do we have to be concerned with anything going on in washington with the debate over health care and your products? >> in our case not really. most of our patients are already over 65 and covered by medicare. so we're really not affected by what's going on in today's event. plus our products are life saving for the critically ill. >> you do have a lot of different products being tested. you've got some right now pretty

revolutionary in the pipe? >> yes a few things are going on. one is this group of patients with aortic stenosis, they're largely undertreated >> i was shocked when i read that, there' more than 600,000 people and only -- how is that possible is it someone not doing their job? >> it's easy to misdiagnose. it just seems like you're getting old, you're losing your energy, yeah, you're out of breath -- >> not like us >> so it gets misdiagnosed and sometimes they don't move through the system the fact is this disease is like a cancer it just gets worse >> you have done a remarkable job. it's long been one of my favorites. chairman of edwardslife sciences i don't think this stock is done going up, it's a revolutionary technology company and they keep doing great things you always pay

your insurance on time. tap one little bumper, and up go your rates. what good is having insurance if you get punished for using it? news flash: nobody's perfect. for drivers with accident forgiveness, liberty mutual won't raise your rates due to your first accident. switch and you could save $782 on home and auto insurance. call for a free quote today. liberty stands with you™ liberty mutual insurance. she can't become a guitar legend just by playing air guitar. the baby's room won't build itself. and her paw won't heal on its own. we're all working forward to something. synchrony financial can help your customers make it happen sooner. so she can plug into her dreams... and they'll have a new addition for their new addition. whatever you're working forward to, even if it's chasing squirrels, synchrony financial can help you get there.

it is time for the lightning round! and then the lightning round is over are you ready skee-daddy scott in north carolina. scott! >> caller: big charlotte booyah from my family to yours. may not like this one but game stop -- >> no, no, they keep trying but can't put it together. we don't want to be there but we do like act vision wizard, electronic carts and take two interactive. guy in illinois. >> caller: booyah.

>> what you got there, guy >> caller: jim >> yeah. >> caller: first time caller >> excellent >> just wanted to know what your thoughts are, is this a good time to buy pfizer >> no one ever got hurt buying pfizer i'd like to see some new product or a big acquisition or the splitup they've been talking about. it's not going to run away from you. barbara in michigan. >> caller: hi, jim booyah thank you for taking my call >> of course >> caller: i'm looking at imth, amphastar pharmaceuticals but we have two companies taking them to court >> why do we need that we have so many high quality biotechs i know it's a 500 but you can only buy maybe ten years, it's worth doing. let's go to charlie in pennsylvania charlie! >> caller: thank you for teaching me stock fundamentals

you have been my favorite instructor by far. >> thank you >> stock that i'm looking at is a regional, it spiked up after the election and looks like it's building a case and expect dividend heights, that's community bank systems >> think about it. citi reported an unbelievable quarter, stock is down a couple bucks, jpmorgan good quarter and stock's off 4. i just can't go there. pnc is better. stick with the majors that have come down. morgan stanley, congratulations in mike gordon >> michael in massachusetts. >> caller: hi. i'm talking about nabors industries >> no. this is a guy, i really don't like this. i lump this in with transocean and diamond offstar. halliburton is a good report see what they have to say.

no, too speculative. >> les in virginia >> caller: thanks for s for ta call thanks for recommending visa >> don't buy it until end of the quarter. >> caller: cypress semiconductor? >> i like cypress. i don't like the management turmoil. omar in florida. omar >> caller: booyah, jim cramer. >> yes >> caller: i got a question for you. mazer robotics >> the issue with mazeor was not the product. it was the fact that the israeli fcc raided their system. but mazeor the product, upgraded again. continues to go higher john in new york

>> caller: how you doing, jim? >> good. >> caller: sarta >> it's a pipe company for forterra >> pipe sales, their actual targ owe, are way down. too much pipe involved with infrastructure let's see what newcorps says t see if there's hope for infrastructure that, ladies and gentlemen, is the conclusion of the lightning round! >> the lightning round is sponsored by td ameritrade trading platform wherever i go. you know that thinkorswim seamlessly syncs across all your devices, right? oh, so my custom studies will go with me? anywhere you want to go! the market's hot! sync your platform on any device with thinkorswim. only at td ameritrade

to keep our community safe. before you do any project big or small, pg&e will come out and mark your gas and electric lines so you don't hit them when you dig. call 811 before you dig, and make sure that you and your neighbors are safe.

811 is available to any business our or homeownerfe. to make sure that you identify where your utilities are if you are gonna do any kind of excavation no matter how small or large before you dig, call 811. keep yourself safe.

we need to talk about this incredible run in ptla, portola pharmaceutica pharmaceuticals. you'll want to hear about this this is a development stage biotech. you may never have heard of this one. but it has rocketed 190% year to date, including a staggering 78% just in the past month this kind of move is is exactly why i always tell you it's worth speculating in high-risk, high-reward stocks with development stage biotechs being some of the best examples because when they work, they really work. but on the other hand, when they blow up in your face, you can get hurt very badly. over a year ago portola was pretty much the poster child for biotech disasters. after running up most of 2015,

the stock tumbled from $50 to high teens in months it's a textbook example of what makes it so dangerous. you should only ever own stocks with this one with money you can afford to lose you hear that? money you can afford to lose this is not a 401(k)-ira situation. it's an example, though, of why taking the kind of risk can be worthwhile what the heck is going on with this one how did the stock go from zero to hero in less than a year. it's a biotechnical that specializes in treating blood clots and other blood diseases the company's lead drug is an anti-coagulant that helps to prevent blood clots from getting worse. it was just approved by the fda a month ago. the market for this drug alone

could be worth $3 billion. it's much longer acting than the current standard of care and it's better at preventing venus tlom bow embolisms, blood clots that start in the vein the company itself is conservative it's not just a one-drug wonder, which is why -- i wouldn't give it the time if it was that dangerous. they have two more therapies in the pipeline the first is being reviewed by the fda, a drug designed to reverse the effects of a certain type of anti-coagulant if you watched enough "house," these drugs can be very dangerous. they might prevent from you getting a stroke but they can also cause uncontrolled bleeding that can become lethal if you need surgery that's why they've become with the first anti-coagulant reversal agent that works against fsa inhibitors if the doctor gives you too much

anti-coagulant, think can give you their compound and put things back to normal. the only other drugs in the class tend to cause strokes or heart attacks. but it's still being reviewed by the fda so we can't say for sure it will be improved but it will serve an incredible unmet need third, they're working on a blood cancer therapy currently in phase two trials. they're studying it as a treatment for various b cell ma lig nancys in patients who have already tried other drugs without success. why has the stock been such a wide trader? in 2015 the company caught fire as it got positive late stage trial results on its anti-coagulant and anti-an anti-anti-coagula anti-anti-coagulant. last year investors got a lot more critical of these particular kind of companies, the development stage, ones that don't make money that's why they were cut in half in 2016. there were some real company

specific factors in play, too. they reported very confusing phase three clinical trial data on their anti-clotting drug. it did well across the whole study but failed to outperform against the current standard of care in a particular subset of at-risk patients that's less bad news than mixed news but in an environment like last year, it really hurt the stock. when they submitted their drug to the fda, the regulators asked them for more information rather than improve the therapy, often code for this drug's in big trouble, which is why their stock ultimately lost 56% of its value last year. however, in 2017 it's become roaring back the stock is up 190% year to date and reached an all-time high the biotechs have come back into

favor, rejenner on, celgene. it's more friendly environment makes it easier to buy stocks like portola hand over fist when certainly's going right. a lot has gone right in the past few months they made a deal with health care royalty, in exchange for 50 million up front and more if it gets fda approval. then we got encouraging signs on byvexa, the anti-clotting therapy and a little less than a month ago, the regulators flat out gave the drug their approval bevyxxa is going to roll out sometime this fall and it's huge it's much better than any anti-coagulants on the market. the stock rallied 46% in three

hours. citigroup raised its price target it's climbed higher to nearly 65 today. while that may seem like a ridiculously dramatic move, the fact is these things happen all the time in biotech. if the fda rejected their drug, the stock would have been eviscerated. instead it got approved and it was launched into the stratosphere early the only thing that matters is fda approvals everything before that is reading tea leaves but the thing about portola is it's no longer a precarious product. it's going to hit the market we'll be watching to see how

many scripts are filed we'll have to do a lot of day to day. very soon it's going to be a real company, real revenue and it's still got two more drugs in the pipeline that could represent a lot of potential up side if things go right. and if things go wrong well, it might be okay here because portola's lead drug has already been approved so it has a lot less down side than when it got obliterated last year even if they stumble when it comes to the -- the won't be cut in half this time. a here's the bottom line sure it's already rocketed higher that's because getting roar lead drug approved by the fda is a game changer if you're looking to speculate on a relatively young biotech, you have my blessing but you should way until the next market wide pullback. i do believe that a portola has

a huge amount of success, it will garner the attention of the big dogs is this another version of "a star is born," one with the potential to be the next vertex, a stock up 27% today and a break throu through? there's more here than a one-trick pony that can blow up in your face on a moment's notice stick with cramer. we talked about a lot of positives, some negatives. it's like they're spending too much to get new cardholder and

ibm was down hideously today ibm looks like a fourth quarter situation before we see up revenues 21 straight quarters of down revenues there's always a bull market somewhere. i promise to try to find it just for you right here on "mad money. i'm jim cramer i will see you tomorrow! they'll invest their own money or fight each other for a deal. this is "shark tank." ♪ my name is barbara lampugnale, and i live in west hartford, connecticut. i am a mother of six girls, two of which have gone off to college. (chuckles) my girls and i absolutely love doing fun things together, so on sunday nights, it's become tradition that we all get together and paint each other's nails. do toesies. it was on one of these nail nights where my idea just hit me. wow.